top of page

CSI is featured in the latest Outsourcing in Clinical Trial Supply (OCT) Handbook 

Updated: Aug 1

We discuss comparator medicines' importance in arena international's 2023 outsourcing in clinical trials handbook

Our article entitled ’Budgeting for Clinical Trials: The Importance of Comparator Medicines’ appears in the 2023 Outsourcing in Clinical Trials (OCT) handbook by Arena International.

Due to the number of global trials and their complexity increasing, and drug shortages becoming more prevalent, sourcing comparator drugs has become more difficult. 

With over 25 years of experience supplying clinical trials, we have gained a deep understanding of the availability of comparator drugs across the globe and what considerations organisations should take when creating their clinical trial budget.  

The OCT handbook is the go-to guide for professionals in the global clinical outsourcing space, with insights from leading industry experts, including Clinical Services International. 

Read our feature here

What we highlight 

  • General considerations when preparing a clinical trial budget 

  • Ethical considerations and competition among clinical trials driving comparator demand

  • Factors to consider when building your comparator sourcing budget

  • Risk mitigation in comparator sourcing

As the article explains, budgeting for comparator drugs isn’t a simple process, with numerous pitfalls that can occur. As a result, having a comparator drugs supplier who can overcome the challenges is essential.  

With our network of over 95 manufacturers across over 50 countries and 6 continents, Clinical Services International can optimise your comparator sourcing strategy and ensure that high-quality, on-time, and on-budget comparator drugs are delivered to your clinical trial.

If you enjoyed reading our article and want to discuss your clinical trial requirements with CSI, please  contact us  today. 

bottom of page